AAAAAA
Results: 1-25/26
Authors:
Baechtold, F
Scott, JA
Markert, M
Mehta, S
McCormack, DG
Anglada, F
Galaud, D
Vaglio, M
Waeber, B
Feihl, F
Citation: F. Baechtold et al., Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture?, SHOCK, 16(2), 2001, pp. 137-142
Authors:
O'Brien, E
Waeber, B
Parati, G
Staessen, J
Myers, MG
Citation: E. O'Brien et al., Blood pressure measuring devices: recommendations of the European Society of Hypertension, BR MED J, 322(7285), 2001, pp. 531-536
Authors:
Waeber, B
Citation: B. Waeber, Treatment strategy to control blood pressure optimally in hypertensive patients, BLOOD PRESS, 10(2), 2001, pp. 62-73
Authors:
Waeber, B
Citation: B. Waeber, Achieving blood pressure targets in the management of hypertension, BLOOD PRESS, 10, 2001, pp. 6-12
Authors:
Sieg-Dobrescu, D
Burnier, M
Hayoz, D
Brunner, HR
Waeber, B
Citation: D. Sieg-dobrescu et al., The return of increased blood pressure after discontinuation of anti hypertensive treatment is associated with an impaired post-ischemic skin blood flow response, J HYPERTENS, 19(8), 2001, pp. 1387-1392
Authors:
Waeber, B
Brunner, HR
Citation: B. Waeber et Hr. Brunner, The multifactorial nature of hypertension: the greatest challenge for its treatment?, J HYPERTENS, 19, 2001, pp. S9-S16
Authors:
Waeber, B
Aschwanden, R
Sadecky, L
Ferber, P
Citation: B. Waeber et al., Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone, J HYPERTENS, 19(11), 2001, pp. 2097-2104
Authors:
Haefliger, JA
Demotz, S
Braissant, O
Suter, E
Waeber, B
Nicod, P
Meda, P
Citation: Ja. Haefliger et al., Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension, KIDNEY INT, 60(1), 2001, pp. 190-201
Authors:
Baechtold, F
Cavadas, C
Gasser, D
Markert, M
Grouzmann, E
Peterson, KL
Waeber, B
Feihl, F
Citation: F. Baechtold et al., Cardiovascular effects of fentanyl in conscious rats, PFLUG ARCH, 443(1), 2001, pp. 155-162
Authors:
Waeber, B
Citation: B. Waeber, A review of irbesartan in anti hypertensive therapy: Comparison with otheranti hypertensive agents, CURR THER R, 62(7), 2001, pp. 505-523
Authors:
Kubli, S
Feihl, F
Waeber, B
Citation: S. Kubli et al., Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation, CLIN PHARM, 69(4), 2001, pp. 238-244
Authors:
Waeber, B
Citation: B. Waeber, Blood pressure control: a review on irbesartan, EUR H J SUP, 2(B), 2000, pp. B2-B7
Authors:
Denolle, T
Waeber, B
Kjeldsen, S
Parati, G
Wilson, M
Asmar, R
Citation: T. Denolle et al., Self-measurement of blood pressure in clinical trials and therapeutic applications, BL PRESS M, 5(2), 2000, pp. 145-149
Authors:
Waeber, B
Citation: B. Waeber, Proceedings from a Workshop on Measurement of Blood Pressure of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension, Milan, June 1999, BL PRESS M, 5(1), 2000, pp. 31-32
Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function
Authors:
Kubli, S
Waeber, B
Dalle-Ave, A
Feihl, F
Citation: S. Kubli et al., Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function, J CARDIO PH, 36(5), 2000, pp. 640-648
Authors:
Waeber, B
Burnier, M
Brunner, HR
Citation: B. Waeber et al., How to improve adherence with prescribed treatment in hypertensive patients?, J CARDIO PH, 35, 2000, pp. S23-S26
Authors:
Waeber, B
Citation: B. Waeber, New recommendations for the treatment of hypertension: A theoretical concept or a useful tool in practice?, SCHW MED WO, 130(1-2), 2000, pp. 5-7
Authors:
Waeber, B
Brunner, HR
Citation: B. Waeber et Hr. Brunner, Clinical applications and limitations in the use of AT(1) receptor antagonists, V CH MO CAR, 1, 2000, pp. 159-170
Authors:
Waeber, B
Vetter, W
Darioli, R
Keller, U
Brunner, HR
Citation: B. Waeber et al., Improved blood pressure control by monitoring compliance with antihypertensive therapy, INT J CL PR, 53(1), 1999, pp. 37-38
Authors:
Waeber, B
Burnier, M
Brunner, HR
Citation: B. Waeber et al., Compliance with antihypertensive therapy, CLIN EXP HY, 21(5-6), 1999, pp. 973-985
Authors:
Waeber, B
Detry, JM
Dahlof, B
Puig, JG
Gundersen, T
Hosie, J
Januszewicz, W
Lindstrom, CJ
Magometschnigg, D
Safar, M
Tanser, P
Toutouzas, P
Citation: B. Waeber et al., Felodipine-metoprolol combination tablet: A valuable option to initiate antihypertensive therapy?, AM J HYPERT, 12(9), 1999, pp. 915-920
Authors:
Waeber, B
Leonetti, G
Kolloch, R
McInnes, GT
Citation: B. Waeber et al., Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study, J HYPERTENS, 17(7), 1999, pp. 1041-1045
Authors:
Haefliger, JA
Waeber, B
Grouzmann, E
Braissant, O
Nussberger, J
Nicod, P
Waeber, G
Citation: Ja. Haefliger et al., Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats, REGUL PEPT, 82(1-3), 1999, pp. 35-43
Authors:
Schwed, A
Fallab, CL
Burnier, M
Waeber, B
Kappenberger, L
Burnand, B
Darioli, R
Citation: A. Schwed et al., Electronic monitoring of compliance to lipid-lowering therapy in clinical practice, J CLIN PHAR, 39(4), 1999, pp. 402-409
Authors:
Waeber, B
Burnier, M
Brunner, HR
Citation: B. Waeber et al., Comment on the treatment of arterial hypertension, SCHW MED WO, 129(1-2), 1999, pp. 14-16